Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28- 31 August 2026.

This flagship global event brings together cardiology leaders, researchers, and innovators to advance cardiovascular medicine through groundbreaking science, clinical insights, and collaborative solutions.

Representing Richmond Pharmacology

  • Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Innovations in cardiovascular drug development
  • Clinical trial design for complex cardiac conditions
  • Regulatory pathways for novel therapies
  • Patient-centric approaches and recruitment strategies
  • Collaboration between academia, industry, and regulators

Connect With Us

If you are attending ESC Congress 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍

Latest news

Leadership Spotlight - Head of Pharmacovigilance

November 16, 2026
Amina Ghareeb on Building Richmond's Pharmacovigilance Expertise
Read more

Upcoming Event

JSCPT 2026

27 - 28 November 2026
Richmond Pharmacology is excited to join the JSCPT Annual Meeting 2026 in Tokyo, Japan, on 27-28 November 2026.
View event